In our current study we confirm upregulation of TGFβ and MAPK signalling pathways in primary fibroblasts isolated from OI patients with COL1A1 mutations, demonstrating that these cells retain their OI phenotype in culture. The gene discussed is TGFB1; the disease is osteogenesis imperfecta.